French pharmaceutical maker DBV Technologies says researchers in a Phase 2 trial of the Viaskin Milk patch observed “statistically significant… Read more »
French pharmaceutical maker DBV Technologies says researchers in a Phase 2 trial of the Viaskin Milk patch observed “statistically significant… Read more »